For May 19, 1999

Dr. Thomas Waldmann is chief of the NCI's Metabolism Branch. He earned his medical degree from Harvard and interned at Massachusetts General Hospital before joining NCI in 1956. He has devoted his career to NCI, and has headed the Metabolism Branch since 1971.

Dr. Waldmann's work in basic and clinical immunology focuses on the regulation of the human immune response and the disorders of this regulation in immunodeficiency diseases and malignancy.

Dr. Waldmann was the first to define and study suppressor T cells in humans. He co-discovered a novel lymphokine, IL-15, that stimulates T cell proliferation, and is critically involved in the development and activation of natural killer cells.



Dr. Franklin Neva
heads the Section on Opportunistic Parasitic Diseases, in NIAID. Dr. Neva earned his medical degree at the University of Minnesota Medical School. He spent a year as an intern at Boston City Hospital and then two years on active duty with a Naval medical research unit in Cairo. He returned to Boston City Hospital for a year of residency in internal medicine and completed a fellowship in microbiology at Harvard.

Dr. Neva held a number of positions at Harvard School of Public Health and elsewhere before joining NIAID in 1969 as chief of its Laboratory of Parasitic Diseases, where he has been ever since. He has had a long and distinguished research career studying infectious diseases such as leishmaniasis, Chagas' disease, malaria, and strongyloidiasis.



current cc grand rounds | past grand rounds

cc home

nih home

Questions about the Clinical Center or CC grand rounds? OCCC@nih.gov

Or call: (301) 496-2563

National Institutes of Health, Warren Grant Magnuson Clinical Center, Bethesda, Maryland 20892. Last modified 5/99